Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,894 | 92,933 | 102,304 | 298,887 | 553,439 |
| Marketable Securities | 131,106 | 124,575 | 59,374 | 15,876 | 51,987 |
| Receivables | 129,185 | 51,093 | N/A | 1,389 | N/A |
| Inventories | 110,458 | 39,823 | N/A | N/A | N/A |
| Other current assets | 15,716 | 9,519 | 2,359 | 2,884 | 1,083 |
| TOTAL | $566,359 | $317,943 | $168,274 | $330,965 | $611,740 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 307 | 600 | 481 |
| Investments And Advances | 808 | 0 | 12,404 | 35,533 | 0 |
| Intangibles | 0 | 0 | 799 | 799 | 799 |
| Other Non-Current Assets | 10,523 | 11,644 | 11,788 | 11,732 | 12,622 |
| TOTAL | $11,331 | $11,644 | $25,298 | $48,664 | $13,902 |
| Total Assets | $577,690 | $329,587 | $193,572 | $379,629 | $625,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 975 | N/A |
| Accounts payable and accrued liabilities | 58,296 | 38,471 | 42,019 | 51,294 | 37,014 |
| Accrued Expenses | 15,185 | 12,172 | 8,432 | 10,166 | 8,456 |
| Other current liabilities | 4,627 | 1,479 | 1,169 | 1,512 | 18,236 |
| TOTAL | $90,679 | $53,720 | $53,201 | $65,384 | $87,554 |
| Non-Current Liabilities | |||||
| Long Term Debt | 244,429 | 100,118 | 71,135 | 66,788 | 7,716 |
| Deferred Revenues | 11,414 | 152 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 8,133 | 9,231 | 10,344 | 9,847 | 10,412 |
| TOTAL | $264,647 | $115,365 | $81,784 | $77,092 | $18,738 |
| Total Liabilities | $355,326 | $169,085 | $134,985 | $142,476 | $106,292 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 157,071 | 154,421 | 146,363 | 142,817 | 140,586 |
| Common Shares | 156 | 151 | 146 | 143 | 141 |
| Retained earnings | -1,529,194 | -1,552,577 | -1,527,033 | -1,328,698 | -980,597 |
| Other shareholders' equity | 6 | -234 | -234 | -234 | -234 |
| TOTAL | $222,364 | $160,502 | $58,587 | $237,153 | $519,350 |
| Total Liabilities And Equity | $577,690 | $329,587 | $193,572 | $379,629 | $625,642 |